CINECA IRIS Institutional Research Information System

CERAVOLO, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.195
EU - Europa 7.059
AS - Asia 2.309
AF - Africa 317
SA - Sud America 20
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
Totale 25.928
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.811
IT - Italia 2.802
SE - Svezia 1.370
CN - Cina 1.068
BG - Bulgaria 768
DE - Germania 569
SG - Singapore 519
CA - Canada 380
GB - Regno Unito 338
AT - Austria 311
VN - Vietnam 285
UA - Ucraina 259
FI - Finlandia 219
TR - Turchia 207
CI - Costa d'Avorio 188
CH - Svizzera 116
RU - Federazione Russa 103
HK - Hong Kong 94
IN - India 88
SN - Senegal 68
FR - Francia 56
NG - Nigeria 46
PL - Polonia 34
BE - Belgio 29
CZ - Repubblica Ceca 18
NL - Olanda 17
IE - Irlanda 15
AU - Australia 14
ES - Italia 13
KR - Corea 13
BJ - Benin 11
EU - Europa 11
JP - Giappone 10
BR - Brasile 8
IR - Iran 8
AR - Argentina 5
CO - Colombia 5
IL - Israele 5
EE - Estonia 4
GR - Grecia 4
TW - Taiwan 4
MX - Messico 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
HR - Croazia 2
MA - Marocco 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
IM - Isola di Man 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 25.928
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.951
Fairfield 1.863
Ann Arbor 1.348
Houston 1.326
Chandler 1.266
Ashburn 1.045
Milan 834
Seattle 801
Sofia 768
Wilmington 693
Cambridge 583
Serra 523
New York 505
Boardman 400
Jacksonville 394
Princeton 382
Beijing 368
Ottawa 362
Lawrence 301
Vienna 291
Medford 279
Singapore 216
Izmir 192
Abidjan 188
Nanjing 188
Des Moines 178
Pisa 177
Florence 168
Dearborn 154
Frankfurt am Main 144
Bern 113
Dong Ket 112
San Diego 99
Hong Kong 86
Rome 83
London 80
Nanchang 79
Bremen 75
Dakar 68
Jüchen 67
Redwood City 65
Norwalk 59
Ogden 59
Lancaster 58
Chicago 51
Los Angeles 50
Shenyang 50
Kunming 48
Lagos 46
Hebei 44
Pune 35
Guangzhou 34
Warsaw 32
Changsha 31
Brussels 29
Vicopisano 29
Hefei 26
Trieste 26
Tianjin 25
Jiaxing 24
Boulder 22
Falls Church 22
Washington 19
Lucca 18
San Francisco 17
Dallas 16
Hangzhou 16
Nürnberg 16
Brno 15
Auburn Hills 14
Hyderabad 12
Livorno 12
Phoenix 12
Cotonou 11
Jinan 11
Kent 11
La Spezia 11
Shanghai 11
Düsseldorf 10
Helsinki 10
Munich 10
Costa Mesa 9
Detroit 9
Santa Clara 9
Verona 9
Viareggio 9
Council Bluffs 8
Haikou 8
Massa E Cozzile 8
Medolago 8
Changchun 7
Indiana 7
Istanbul 7
Messina 7
Orange 7
Palaia 7
San Giuliano Terme 7
Central District 6
Edinburgh 6
Kilburn 6
Totale 20.011
Salva come PNG Salva come JPEG
Nome #
Cataract surgery under topical anesthesia in a patient with Parkinson disease and deep brain stimulation: a report of feasibility. 249
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 244
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 176
Disfunzioni sessuali nel morbo di Parkinson: review 164
A case of pelvic floor myoclonic jerk syndrome. 162
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 159
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 149
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 149
Leadless cardiac pacemaker implant in a patient with two deep brain stimulators: a peaceful cohabitation beyond prejudices 148
Acute and chronic effects of clozapine in essential tremor 147
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 146
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 146
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 144
Mitochondrial DNA single deletion in a patient with postural tremor. 143
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 141
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 140
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result 140
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 140
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 140
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 138
The hOGG1 Ser326Cys polymorphism and Huntington's disease 136
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 136
Serotonin and neurodegeneration: a preliminary study of platelet serotonin transporter (SERT) in patients with Huntington's disease 136
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 135
Social Cognition and Oxytocin in Huntington’s Disease: New Insights 131
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 129
SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study 128
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 128
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 128
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 128
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 126
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 125
Psychosis associated to Parkinson's disease in the early stages: Relevance of cognitive decline and depression 125
null 125
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 124
Iowa Gambling Task in de novo Parkinson's disease: a comparison between good and poor performers 123
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients 123
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 122
Decision making in de novo Parkinson's disease 121
The association between motor subtypes and alexithymia in de novo Parkinson's disease. 119
Non-motor symptoms in atypical and secondary parkinsonism: The PRIAMO study 119
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 119
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 118
Myopathic involvement in two cases of Hallervorden-Spatz disease 117
Depressive symptoms in Parkinson's disease 117
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study. 116
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 116
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 116
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 115
Current treatment and future prospects of dopa-induced dyskinesias. 115
Antipsychotic drugs in Huntington's disease 115
The mtDNA A8344G "MERRF" mutation is not a common cause of sporadic Parkinson disease in Italian population 114
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 114
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients 113
No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease 112
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy 111
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire 111
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 111
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 110
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. 110
Association between amantadine and the onset of dementia in Parkinson's disease 109
Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in Parkinsonian patients 109
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging 109
Clinical variables associated with treatment changes in Parkinson's disease: results from the longitudinal phase of the REASON study. 109
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 108
Antioxidants in the Diet and Cognitive Function: Which Role for the Mediterranean Life-style? 108
null 108
Unilateral periodic limb movements: is this a pointer for atypical presentation of corticobasal degeneration syndrome?--A case report 107
Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines. 107
Nonmotor symptoms in Parkinson’s disease: the dark side of the moon 106
Role of pramipexole in the management of Parkinsons disease 106
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: new imaging frontiers 106
Morphometric and functional MRI changes in essential tremor with and without resting tremore. 106
Psychiatric comorbidity in a population of Parkinson's disease patients 105
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 105
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items". 105
Apomorphine hydrochloride for the treatment of Parkinson's disease. 105
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 105
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 104
Reliability of administrative data for the identification of Parkinson's disease cohorts. 104
Advances in the pharmacotherapeutic management of dementia with Lewy bodies 104
null 103
The Italian Dystonia Registry: rationale, design and preliminary findings 103
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 103
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 103
Alexithymia is associated with depression in de novo Parkinson's disease 102
Sindrome da encefalopatia posteriore reversibile (PRES) in una paziente psoriasica in trattamento con ciclosporina 101
Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma 101
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 101
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 101
Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease 100
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports 100
A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease. 100
Correlation between vestibular abnormalities and MRI findings in cerebellar ataxia 99
Expanding the clinical phenotype of DYT5 mutations: is multiple system atrophy a possible one? 99
Evaluating the SERCA2 and VEGF mRNAs as potential molecular biomarkers of the onset and progression in huntington's disease 99
Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study 98
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. 98
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia 97
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 97
Totale 12.142
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.987 0 0 448 292 434 568 596 423 520 261 351 94
2020/20212.335 175 164 151 96 197 146 287 186 240 174 136 383
2021/20223.333 44 125 71 254 657 440 93 177 199 99 226 948
2022/20234.345 565 540 344 357 470 546 38 315 776 23 290 81
2023/20243.898 454 414 414 320 570 768 145 136 30 72 182 393
2024/2025613 116 421 76 0 0 0 0 0 0 0 0 0
Totale 26.498